Joel S. Marcus, Chairman, Chief Executive Officer, and Founder of Alexandria Real Estate Equities, Inc. and Alexandria Venture Investments, Elected to the Board of Directors of the Foundation for the National Institutes of Health

PASADENA, Calif., July 10, 2012 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) is pleased to announce that Chairman, Chief Executive Officer, and Founder, Joel S. Marcus, was unanimously elected to the Board of Directors of the Foundation for the National Institutes of Health (FNIH). Among the board members' responsibilities are helping guide the FNIH's mission and purpose; ensuring effective organizational planning; ensuring adequate resources and managing them effectively; reviewing, monitoring, and strengthening the FNIH's programs and services; and enhancing the FNIH's public standing. Other board members include former Chairman and Chief Executive Officer of Glaxo Inc., Charles A. Sanders, M.D.; James H. Donovan, Partner at Goldman Sachs & Company; Freda C. Lewis-Hall, M.D., FAPA, Chief Medical Officer and Executive Vice President of Pfizer Inc.; Paul L. Herrling, Ph.D., Chairman of the Novartis Institute for Tropical Diseases; Steven M. Paul, M.D., former Executive Vice President of Science and Technology and President of the Lilly Research Laboratories of Eli Lilly and Company; and Ellen V. Sigal, Ph.D., Chairperson and Founder of Friends of Cancer Research. Mr. Marcus began his term May 16, 2012.

"The wealth of knowledge Joel possesses will be an asset to the FNIH," stated Charles A. Sanders, MD, Chairman of the FNIH. "He will diversify the knowledge base of our directors and makes a wonderful addition to our board."

"Joel has a long standing commitment to science and a deep understanding of what is needed to foster and encourage creativity and innovation in scientific research," noted Mrs. William McCormick Blair, Jr., FNIH board secretary.

"Having worked closely with a plethora of public and private entities within the broad and diverse life science community for nearly 30 years, I have personally witnessed the critical role that strategic funding for innovative research plays in the development of novel breakthrough discoveries that prevent illness, save lives, improve the quality of life, and significantly reduce the economic burden of disease on society," said Mr. Marcus. "As the global leader in cutting-edge life science research, our nation must continue its commitment to fund this mission-critical, world-class research engine, which is both enormously and positively impactful on human health as well as a major generator of high-quality jobs. I look forward to working alongside my colleagues as a board member of the FNIH to carry out this mission efficiently and effectively."

Mr. Marcus also serves on the boards of the Accelerator Corporation, of which he was one of the original architects and co-founders, Intra-Cellular Therapies, Inc., and Research!America.

About Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc. (NYSE: ARE) is the largest and leading investment-grade real estate investment trust focused principally on owning, operating, and developing high-quality, sustainable real estate for the broad and diverse life science industry.  Founded in 1994, Alexandria has the first-mover advantage in every core life science cluster location, including Greater Boston, San Francisco Bay, San Diego, New York City, Seattle, Suburban Washington, D.C., and Research Triangle Park. Alexandria's high-credit client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, U.S. government research agencies, medical device companies, clean technology companies, venture capitalists, and life science product and service companies. As the recognized real estate partner of the life science industry, Alexandria has a superior track record in driving client tenant productivity and innovation through its best-in-class laboratory and office space, collaborative locations proximate to leading research institutions, unparalleled life science real estate expertise and services, and longstanding and expansive network in the life science community. For additional information on Alexandria Real Estate Equities, Inc., please visit www.are.com.

This press release contains forward-looking statements within the meaning of the federal securities laws. Actual results may differ materially from those projected in the forward-looking statements. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained in our Annual Report on Form 10-K and our other periodic reports filed with the Securities and Exchange Commission.

SOURCE Alexandria Real Estate Equities, Inc.